Terazosin Hydrochloride
NDC 69292-202, Terazosin Hydrochloride, capsule, from Amici Pharma, Inc..
- Product NDC
- 69292-202
- Status
- Listed
- Labeler
- Amici Pharma, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074823
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69292-202 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69292-202-01 | 69292020201 | 100 CAPSULE in 1 BOTTLE (69292-202-01) |
| 69292-202-10 | 69292020210 | 1000 CAPSULE in 1 BOTTLE (69292-202-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4007dbd3-e850-43e7-8a56-8735e31063cd
Use it
Look up 69292-202 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69292-202 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69292-202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.